Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Director Shareholding - AMENDMENT

20 Jul 2016 16:59

RNS Number : 7875E
First Derivatives PLC
20 July 2016
 

20 July 2016

 

Amendment of RNS 6526E published at 17:03 on 19 July 2016 - The only amendment made to the below announcement is to change the date of admission of the new Ordinary Shares to trading on AIM and ESM from 22 July 2016 to 25 July 2016

 

First Derivatives plc

("FD" or the "Company")

 

Director dealing and issue of equity

 

 

FD (AIM: FDP.L, ESM: FDP.I) announces that on 18 July 2016 certain employees and a Director exercised options over a total of 217,000 ordinary shares of 0.5p each in the Company ("Ordinary Shares"). Of this total exercise, Graham Ferguson, Chief Financial Officer, exercised 150,000 share options and on the same day sold 170,000 Ordinary Shares at a price of 1,725p per share. On 19 July Mr Ferguson sold a further 30,000 Ordinary Shares at a price of 1,725p. Following these transactions Mr Ferguson holds a total of 122,647 Ordinary Shares representing 0.5% of the total issued share capital of the Company.

 

Furthermore, on 19 July 2016 Mr Ferguson was awarded 200,000 share options over Ordinary Shares. These options have an exercise price of 1,717p per share and will vest on the third anniversary of the date of the award, subject to meeting demanding performance criteria related to the achievement of total shareholder returns during this period. Following this award, Mr Ferguson holds share options over a total of 200,000 Ordinary Shares.

 

As a result of the above exercise of options, application has been made for 217,000 new Ordinary Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 25 July 2016. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares. Following this allotment, the total issued share capital of the Company will increase to 24,531,639 Ordinary Shares.

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,600 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHRMMATMBATBLF
Date   Source Headline
17th Feb 201512:05 pmRNSIssue of Equity from exercise of share options
17th Feb 20157:00 amRNSEnterprise Securities Market Notice
12th Feb 20157:00 amRNSGBP15.3m Placing for Fast Data Opportunities
30th Jan 20152:22 pmRNSTotal Voting Rights
15th Jan 20157:00 amRNSEnterprise Securities Market Notice
9th Jan 201512:25 pmRNSExercise of Share Options
7th Jan 20157:00 amRNSEntry into Digital Marketing Platform market
31st Dec 20147:00 amRNSTotal Voting Rights
18th Dec 20147:00 amRNSEBS selects Delta Stream
11th Dec 20147:00 amRNSEnterprise Securities Market Notice
5th Dec 20146:00 pmRNSIssue of Equity from exercise of Share Options
28th Nov 20147:00 amRNSTotal Voting Rights
5th Nov 20147:00 amRNSHalf Yearly Report
3rd Nov 20147:00 amRNSEnterprise Securities Market Notice
31st Oct 20142:01 pmRNSSecures a majority shareholding in Kx Systems
23rd Oct 20147:00 amRNSNotice of Results
17th Oct 20147:00 amRNSMajority Shareholding in Kx Systems Secured
2nd Oct 20147:00 amRNSContract Win, Trading Update & Appointment
1st Oct 20147:00 amRNSTotal Voting Rights
26th Sep 20147:00 amRNSWinner of Market Surveillance System of the Year
11th Sep 20147:00 amRNSEnterprise Securities Market Notice
5th Sep 20144:48 pmRNSIssue of Equity from exercise of Share Options
1st Aug 201412:00 pmRNSTotal Voting Rights
1st Aug 20147:00 amRNSEnterprise Securities Market Notice
28th Jul 20143:21 pmRNSIssue of Equity
10th Jul 20147:00 amRNSEnterprise Securities Market Notice
4th Jul 20143:50 pmRNSIssue of Equity
30th Jun 201412:00 pmRNSMINISTER ANNOUNCES £3.9 MILLION GRANT
30th Jun 201411:18 amRNSTotal Voting Rights
27th Jun 20143:23 pmRNSResult of AGM
11th Jun 20146:06 pmRNSHolding(s) in Company
10th Jun 20147:00 amRNSEnterprise Securities Market Notice
9th Jun 20144:23 pmRNSHolding(s) in Company
6th Jun 20145:10 pmRNSDirector's shareholding/Excercise of share options
30th May 20147:00 amRNSDelta Flow integrates FX Surveillance capabilities
20th May 20147:00 amRNSYieldbroker Pty Ltd chooses Delta Surveillance
20th May 20147:00 amRNSFinal Results
13th May 20144:33 pmRNSHolding(s) in Company
13th May 20147:00 amRNSNotice of Results
31st Mar 20149:00 amRNSTotal Voting Rights
26th Mar 20147:00 amRNSTrading Update
20th Mar 20147:00 amRNSDelivery of Pivotal Powered Next Gen Applications
17th Mar 20147:00 amRNSPartnership with Chapdelaine FX
11th Mar 20147:00 amRNSEnterprise Securities Market Notice
5th Mar 20145:32 pmRNSIssue of Equity
5th Mar 20143:59 pmRNSEnterprise Securities Market Notice
28th Feb 201412:00 pmRNSTotal Voting Rights
28th Feb 20147:00 amRNSRedshift Horizons deferred consideration payment
24th Feb 201410:46 amRNSDirector/PDMR Shareholding
13th Feb 20147:00 amRNSEnterprise Securities Market Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.